By Cort Johnson in Health Rising.
Since February, Health Rising has described the development of a new drug produced for chronic fatigue syndrome (ME/CFS) by a small pharmaceutical company named Cortene in three blogs:
- The Cortene Way: New Drug to Be Trialed in Chronic Fatigue Syndrome (ME/CFS) Soon – Pt. I
- Cortene II: A New Drug & A New Hypothesis For Chronic Fatigue Syndrome (ME/CFS)
- Cortene – A New Drug for Chronic Fatigue Syndrome (ME/CFS) Pt III: The Clinical Trial
Now it’s time to test the drug! Cortene’s trial has received the go-ahead from both the FDA and the Independent Review Board (IRB) and the trial will commence shortly, with Lucinda Bateman, MD, as the Principal Investigator, Suzanne Vernon, PhD, as Co-Investigator, and assisted by the experienced clinical trials team at the Bateman Horne Center.
To read the rest of this story, click on the link below: